How to Buy Transmedics Group Stock
Transmedics Group Inc
TransMedics Group, Inc. , a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Transmedics Group stock last closed at $129.19, down 3.12% from the previous day, and has decreased 16.11% in one year. It has overperformed other stocks in the Medical Devices industry by 0.04 percentage points. Transmedics Group stock is currently +134.89% from its 52-week low of $55.00, and -27.16% from its 52-week high of $177.37.
At the moment, there are 33.83M shares of TMDX outstanding. The market cap of TMDX is $4.37B. In the last 24 hours, 370,000 TMDX shares were traded.
How to Buy Transmedics Group Stock
Wondering how to invest in Transmedics Group stock? Here's how.
- Choose where to buy Transmedics Group stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Transmedics Group stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Select your payment method and add your info.
- Research Transmedics Group stock: The Transmedics Group ticker symbol is TMDX. Is Transmedics Group stock a good investment? Should you buy shares of TMDX? How do TMDX's underlying business fundamentals look? Do top analysts think Transmedics Group is a good buy? Why has TMDX's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if TMDX is a good stock to buy).
- Place your TMDX purchase: Decide if you will purchase TMDX shares at the current market price or use a limit order to purchase TMDX stock at a specific price.
- Get notifications regarding your TMDX position: Create a watchlist to watch your position in Transmedics Group shares.
Step 1: Choose where to buy Transmedics Group stock
You will need an online brokerage account to access the NASDAQ market and buy TMDX shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal info so you are able to invest in TMDX today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start a new trading account.
- Send your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the best free stock trading app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing funds into your new brokerage account.
Step 4: Research Transmedics Group stock
After you have chosen the best place to buy Transmedics Group stock, it's crucial to analyze their stock before you buy, so you can comprehend the risk and upside.
Transmedics Group quick stats
Transmedics Group Due Diligence Checks
WallStreetZen was designed to help average investors do better fundamental analysis.
You can view all of the due diligence checks on TMDX's stock page.
How is TMDX stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge TMDX's intrinsic value.
Using relative valuations methods:
- TMDX could be overvalued based on its P/E ratio of 87.88x, relative to Medical Devices industry P/E ratio of 36.28x
- TMDX could be overvalued based on its P/B ratio of 16.41x, relative to Medical Devices industry P/B ratio of 4.1x
- TMDX could be overvalued based on its PEG ratio of 3.02x
You can do more valuation analysis on TMDX's stock here.
TMDX Financial Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the TMDX balance sheet.
- TMDX profit margin has gone up from -3.4% to 10% in the past year.
- TMDX has $310.64M in cash and short term investments. This is enough to cover its annual cash burn of $63.23M.
- TMDX has cash burn of 63227000. It has enough cash and short-term investments to cover this for at least one year.
Failed Health Checks:
- Total TMDX debt is higher than 5 years ago, relative to shareholder equity.
- TMDX has a relatively high debt to equity ratio of 2.15.
- There are more long-term liabilities than short-term assets on the TMDX balance sheet.
Is it a good time to buy Transmedics Group stock, according to analysts?
Out of 3 Equities analysts who track TMDX, the consensus analyst rating on Transmedics Group is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Transmedics Group stock forecast page.
TMDX Technical Indicators
TMDX Growth Numbers
Last year, TMDX revenue was $488.23M. In the past five year, TMDX's revenue has increased by 79.15% per year. This was faster than the Medical Devices industry average of 9.78%.
Dig into TMDX's earnings and revenue performance here.
Who is buying/selling TMDX?
In the past 12 months, executives and large shareholders at TMDX have sold more shares than they have bought.
Anil P. Ranganath, Senior Vice President General Counsel and Secretary of TMDX, was the latest TMDX insider to sell. They sold $95,902.80 worth of TMDX shares on Jun 9, 2025.
Research more about who owns TMDX shares here.
Does TMDX stock generate passive income?
No, Transmedics Group doesn't provide an income stream by paying out dividends.
TMDX Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your TMDX purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and eToro will execute the order.
If you need more assistance buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your TMDX position
Now that you own some TMDX stock, you'll want to keep up with your stock purchase.
Put TMDX on a watchlist to track the latest developments regarding your TMDX stock.
TMDX Feed
How to Buy Stock in Transmedics Group
To summarize, here are the 6 steps you need to take to buy Transmedics Group stock right now:
- Choose where to buy Transmedics Group stock
- Create your brokerage account
- Fund your investment account
- Research Transmedics Group stock
- Place your TMDX purchase
- Get notifications regarding your TMDX position
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Transmedics Group, add TMDX to your watchlist by clicking the button below.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.